Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge
暂无分享,去创建一个
Jeffrey A. Feinstein | Catherine L. Webb | Lorenzo D. Botto | S. Daniels | J. Feinstein | K. Jenkins | A. Correa | C. Warnes | L. Botto | Adolfo Correa | Stephen R. Daniels | Kathy J. Jenkins | Amy E. Britt | Marsha Elixson | Carole A. Warnes | C. Webb | M. Elixson
[1] M. Kirby,et al. Maternal phenylketonuria and phenylalanine restricted diet , 1985, Irish journal of medical science.
[2] J. Saurat,et al. Teratogenic risk with etretinate and acitretin treatment. , 1994, Dermatology.
[3] T R Holford,et al. Exposure to Prescribed Drugs in Pregnancy and Association with Congenital Malformations , 1981, Obstetrics and gynecology.
[4] R. Hamman,et al. Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. , 2005, Diabetes care.
[5] J D Erickson,et al. Racial and temporal variations in the prevalence of heart defects. , 2001, Pediatrics.
[6] Cardiovascular birth defects and antenatal exposure to female sex hormones. , 1977, The New England journal of medicine.
[7] S. Woods,et al. Maternal smoking and the risk of congenital birth defects: a cohort study. , 2001, The Journal of the American Board of Family Practice.
[8] G. Shaw,et al. Maternal Water Consumption During Pregnancy and Congenital Cardiac Anomalies , 1990, Epidemiology.
[9] M. Zack,et al. Paternal age and the occurrence of birth defects. , 1986, American journal of human genetics.
[10] K. Rothman,et al. Vitamin A and birth defects , 1996, The Lancet.
[11] Brentlinger Pe. Folic acid antagonists during pregnancy and risk of birth defects. , 2001 .
[12] K. Overvad,et al. Coffee consumption, birthweight, and reproductive failures. , 1991, Epidemiology.
[13] N. Manley,et al. Effects of excess vitamin A on development of cranial neural crest-derived structures: a neonatal and embryologic study. , 2000, Teratology.
[14] F Vogel,et al. Spontaneous mutation in man. , 1975, Advances in human genetics.
[15] R. Miller,et al. Rarity of coarctation of the aorta in the American Negro. , 1969, The Journal of pediatrics.
[16] G. Shaw,et al. Maternal Periconceptional Vitamins: Interactions with Selected Factors and Congenital Anomalies? , 2002, Epidemiology.
[17] A. Czeizel. Epidemiological Studies of Congenital Abnormalities in Hungary , 1993 .
[18] David B Resnik,et al. The precautionary principle and medical decision making. , 2004, The Journal of medicine and philosophy.
[19] Z. Stowe,et al. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. , 1998, The Journal of clinical psychiatry.
[20] F. Stanley,et al. Birth defects in the infants of Aboriginal and non‐Aboriginal mothers with diabetes in Western Australia , 1992, The Medical journal of Australia.
[21] C. Wasserman,et al. High maternal vitamin A intake and risk of anomalies of structures with a cranial neural crest cell contribution , 1996, The Lancet.
[22] F. Connell,et al. Why Don't Women With Diabetes Plan Their Pregnancies? , 1998, Diabetes Care.
[23] H. Sørensen,et al. Birth outcome of 1886 pregnancies after exposure to phenoxymethylpenicillin in utero. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[24] B. Rosner,et al. No association between coffee consumption and adverse outcomes of pregnancy. , 1982, The New England journal of medicine.
[25] J. Olsen,et al. A population-based case-control teratologic study of ampicillin treatment during pregnancy. , 2001, American journal of obstetrics and gynecology.
[26] C. Moore,et al. Nausea during pregnancy and congenital heart defects: a population-based case-control study. , 1999, American journal of epidemiology.
[27] G. Matanoski,et al. Maternal hormone therapy and congenital heart disease. , 1980, Teratology.
[28] J. Olsen,et al. The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. , 2001, Reproductive toxicology.
[29] F. Dreifuss,et al. Teratogenicity of anticonvulsant drugs. II: A prospective study. , 1984, American journal of medical genetics.
[30] J. Moore,et al. An assessment of lithium using the IEHR Evaluative Process for Assessing Human Developmental and Reproductive Toxicity of Agents. IEHR Expert Scientific Committee. , 1995, Reproductive toxicology.
[31] W. King,et al. Trihalomethanes in public water supplies and adverse birth outcomes. , 1999, Epidemiology.
[32] G. Shaw,et al. Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. , 1995, American journal of medical genetics.
[33] M. Cleves,et al. Maternal Smoking and Congenital Heart Defects , 2008, Pediatrics.
[34] A. R. Murthy,et al. Congenital malformations in an infant born to a woman treated with fluconazole. , 1992, The Pediatric infectious disease journal.
[35] N. Gregg,et al. THE OCCURRENCE OF CONGENITAL DEFECTS IN CHILDREN FOLLOWING MATERNAL RUBELLA DURING PREGNANCY , 1945 .
[36] H. Sørensen,et al. Risk of malformations and other outcomes in children exposed to fluconazole in utero. , 1999, British journal of clinical pharmacology.
[37] J. Scharf,et al. Severe pulmonary hypertension in a neonate caused by premature closure of the ductus arteriosus following maternal treatment with diclofenac: a case report. , 1998, Journal of perinatal medicine.
[38] K. Rothman,et al. Risk of specific congenital abnormalities in offspring of women with diabetes , 2005, Diabetic medicine : a journal of the British Diabetic Association.
[39] D. Stuckey. CONGENITAL HEART DEFECTS FOLLOWING MATERNAL RUBELLA DURING PREGNANCY , 1956, British heart journal.
[40] M. Khoury,et al. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. , 1990, Pediatrics.
[41] C. Wren,et al. Cardiovascular malformations in infants of diabetic mothers , 2003, Heart.
[42] S. Gilbert. Ethical, legal, and social issues: our children's future. , 2005, Neurotoxicology.
[43] J. Jefferson,et al. A reevaluation of risk of in utero exposure to lithium. , 1994, JAMA.
[44] J. Warkany. Teratogen update: lithium. , 1988, Teratology.
[45] D. Srivastava. Genetic assembly of the heart: implications for congenital heart disease. , 2001, Annual review of physiology.
[46] M. Berlan,et al. Developmental remodeling and shortening of the cardiac outflow tract involves myocyte programmed cell death. , 1998, Development.
[47] E. Haan,et al. Maternal diabetes and congenital anomalies in South Australia 1986-2000: a population-based cohort study. , 2005, Birth defects research. Part A, Clinical and molecular teratology.
[48] A. G. Gittenberger-de Groot,et al. Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment. , 2000, Teratology.
[49] Maureen F. Orr,et al. Elevated birth defects in racial or ethnic minority children of women living near hazardous waste sites. , 2002, International journal of hygiene and environmental health.
[50] N. McAlister Gregg,et al. Congenital cataract following German measles in the mother , 2001 .
[51] I. Katz,et al. Teratogenicity of psychotherapeutic medications. , 1987, Psychopharmacology bulletin.
[52] P. Pradat. A case-control study of major congenital heart defects in Sweden — 1981–1986 , 1992, European Journal of Epidemiology.
[53] A. Stergachis,et al. First-Trimester Drug Use and Congenital Disorders , 1981, JAMA.
[54] S Selvin,et al. Maternal Residential Proximity to Hazardous Waste Sites and Risk for Selected Congenital Malformations , 1997, Epidemiology.
[55] S. Colan,et al. Cardiac structure and function in fetuses of mothers infected with HIV: the prospective PCHIV multicenter study. , 2000, American heart journal.
[56] D. Srivastava,et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. , 2007, Circulation.
[57] L. Botto,et al. Maternal Prepregnancy Weight and Congenital Heart Defects in the Offspring , 2001, Epidemiology.
[58] E. K. Turner,et al. FETAL ALCOHOL SYNDROME , 1978, Paediatrics & child health.
[59] D. Green,et al. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. , 1991, The New England journal of medicine.
[60] M. Fulcomer,et al. Public drinking water contamination and birth outcomes. , 1995, American journal of epidemiology.
[61] J. Reefhuis,et al. Maternal age and non-chromosomal birth defects, Atlanta--1968-2000: teenager or thirty-something, who is at risk? , 2004, Birth defects research. Part A, Clinical and molecular teratology.
[62] A. Spitzer,et al. Occurrence of Congenital Heart Defects in Relation to Maternal Multivitamin Use , 2000 .
[63] T. Beaty,et al. Paternal risk factors for isolated membranous ventricular septal defects. , 1997, American journal of medical genetics.
[64] M. Mitchell,et al. Persistent pulmonary hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen. , 1979, Archives of disease in childhood.
[65] E. Bermejo,et al. Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers. , 1998, American journal of medical genetics.
[66] M. Campbell. Place of Maternal Rubella in the Aetiology of Congenital Heart Disease* , 1961, British medical journal.
[67] E. Reece,et al. Prevention of diabetic embryopathy in offspring of diabetic rats with use of a cocktail of deficient substrates and an antioxidant. , 1997, American journal of obstetrics and gynecology.
[68] L. J. Krovetz,et al. Racial Frequencies in Congenital Heart Disease , 1973, Circulation.
[69] K. Rothman,et al. Congenital heart disease in relation to maternal use of Bendectin and other drugs in early pregnancy. , 1985, The New England journal of medicine.
[70] O. Heinonen,et al. Maternal hyperthermia during pregnancy and cardiovascular malformations in the offspring , 1991, European Journal of Epidemiology.
[71] P. Jouppila,et al. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study. , 1995, American journal of obstetrics and gynecology.
[72] J. Warner. Evidence-based psychopharmacology 3. Assessing evidence of harm: what are the teratogenic effects of lithium carbonate? , 2000, Journal of psychopharmacology.
[73] J. Cordero,et al. Maternal diabetes: The risk for specific birth defects , 1992, European Journal of Epidemiology.
[74] M. Khoury,et al. Vitamin A and Cardiac Outflow Tract Defects , 2001, Epidemiology.
[75] K. Flegal,et al. Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.
[76] O. Heinonen,et al. Risk factors for conal malformations of the heart , 1992, European Journal of Epidemiology.
[77] S. Hernández-Díaz,et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. , 2006, The New England journal of medicine.
[78] M. Clementi,et al. High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study. , 1999, Teratology.
[79] T. Einarson,et al. Safety of metronidazole in pregnancy: a meta-analysis. , 1995, American journal of obstetrics and gynecology.
[80] P. Guldberg,et al. Congenital Heart Disease in Maternal Phenylketonuria: Report from the Maternal PKU Collaborative Study , 2001, Pediatric Research.
[81] J. Cordero,et al. Leading major congenital malformations among minority groups in the United States, 1981-1986. , 1988, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.
[82] T. O'brien,et al. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. , 2001, QJM : monthly journal of the Association of Physicians.
[83] C. Walker,et al. Association between maternal obesity and fetal cardiac malformations in African Americans. , 2002, Journal of the National Medical Association.
[84] S. Goldberg,et al. An association of human congenital cardiac malformations and drinking water contaminants. , 1990, Journal of the American College of Cardiology.
[85] O. Heinonen,et al. Risk factors for coarctation of the aorta. , 1993, Teratology.
[86] U. Eriksson,et al. Vitamin E Decreases the Occurrence of Malformations in the Offspring of Diabetic Rats , 1997, Diabetes.
[87] G. Shaw,et al. Congenital cardiac anomalies relative to selected maternal exposures and conditions during early pregnancy , 1992, European Journal of Epidemiology.
[88] W H Dietz,et al. The continuing epidemic of obesity in the United States. , 2000, JAMA.
[89] G. Shaw,et al. Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb. , 1996, Teratology.
[90] F Vinicor,et al. The continuing epidemics of obesity and diabetes in the United States. , 2001, JAMA.
[91] M. Bracken. Drug use in pregnancy and congenital heart disease in offspring. , 1986, The New England journal of medicine.
[92] R. A. Wiseman,et al. Cardiovascular birth defects and antenatal exposure to female sex hormones: a reevaluation of some base data. , 1984, Teratology.
[93] S. Gibson,et al. Congenital heart disease following maternal rubella during pregnancy. , 1952, A.M.A. American journal of diseases of children.
[94] J. Marks,et al. Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination. , 1989, American journal of epidemiology.
[95] A. Correa,et al. Do multivitamin supplements attenuate the risk for diabetes-associated birth defects? , 2003, Pediatrics.
[96] B. Källén,et al. Drinking water chlorination and delivery outcome-a registry-based study in Sweden. , 2000, Reproductive toxicology.
[97] M. Cunningham,et al. Induction of thermotolerance in early postimplantation rat embryos is associated with increased resistance to hyperthermia-induced apoptosis. , 1997, Teratology.
[98] K. Leveno,et al. Maternal Diabetes Mellitus and Infant Malformations , 2002, Obstetrics and gynecology.
[99] A. Ferrara,et al. An Increase in the Incidence of Gestational Diabetes Mellitus: Northern California, 1991–2000 , 2004, Obstetrics and gynecology.
[100] C. Thiels. Pharmacotherapy of psychiatric disorder in pregnancy and during breastfeeding: a review. , 1987, Pharmacopsychiatry.
[101] J. Nora,et al. Can the Pill Cause Birth Defects , 1974 .
[102] K. Rothman,et al. Exogenous hormones and other drug exposures of children with congenital heart disease. , 1979, American journal of epidemiology.
[103] O. Heinonen,et al. Risk factors for cardiovascular malformations in Finland , 1990, European Journal of Epidemiology.
[104] A. Olshan,et al. Paternal age and the risk of congenital heart defects. , 1994, Teratology.
[105] S. Shapiro,et al. Birth defects and drugs in pregnancy , 1977 .
[106] S. Jick. Pregnancy Outcomes after Maternal Exposure to Fluconazole , 1999, Pharmacotherapy.
[107] C. Loffredo,et al. Infants with single ventricle: a population-based epidemiological study. , 2002, Teratology.
[108] A. Eidelman,et al. Indomethacin Tocolysis Increases Postnatal Patent Ductus Arteriosus Severity , 1998, Pediatrics.
[109] O. Heinonen,et al. Risk factors for ventricular septal defect in Finland. , 1991, Public health.
[110] R. McCarter,et al. White-black differences in cardiovascular malformations in infancy and socioeconomic factors. The Baltimore-Washington Infant Study Group. , 1991, American journal of epidemiology.
[111] J. Abraham,et al. Fluconazole-induced congenital anomalies in three infants. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[112] T. Einarson,et al. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. , 1991, Teratology.
[113] B. Graubard,et al. Is moderate drinking during pregnancy associated with an increased risk for malformations? , 1987, Pediatrics.
[114] B. Källén,et al. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. , 2001, Early human development.
[115] H. Levy,et al. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. , 1980, The New England journal of medicine.
[116] L. Itri,et al. Safety of pregnancy after discontinuation of isotretinoin. , 1989, Archives of dermatology.
[117] A. Czeizel. Periconceptional folic acid containing multivitamin supplementation. , 1998, European journal of obstetrics, gynecology, and reproductive biology.
[118] E. Reece,et al. Multifactorial basis of the syndrome of diabetic embryopathy. , 1996, Teratology.
[119] E. Silbergeld,et al. Association of transposition of the great arteries in infants with maternal exposures to herbicides and rodenticides. , 2001, American journal of epidemiology.
[120] T. Buchanan,et al. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. , 2000, American journal of obstetrics and gynecology.
[121] S. Shapiro,et al. Birth defects related to bendectin use in pregnancy. I. Oral clefts and cardiac defects. , 1981, JAMA.
[122] A. Scialli,et al. The developmental toxicity of indomethacin and sulindac. , 1995, Reproductive toxicology.
[123] A. Wilkinson. NAPROXEN LEVELS IN PRETERM INFANTS AFTER MATERNAL TREATMENT , 1980, The Lancet.
[124] G. Shaw,et al. Trihalomethane Exposures from Municipal Water Supplies and Selected Congenital Malformations , 2003, Epidemiology.
[125] S. Shapiro,et al. Multivitamin supplementation and risk of birth defects. , 1999, American journal of epidemiology.
[126] L. W. Perry,et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. , 1985, American journal of epidemiology.
[127] G. Shaw,et al. Ambient air pollution and risk of birth defects in Southern California. , 2002, American journal of epidemiology.
[128] L. Parker,et al. Prevalence of adverse pregnancy outcomes around hazardous industrial sites in Cumbria, north-west England, 1950-93. , 2003, Paediatric and perinatal epidemiology.
[129] Anticonvulsants , 1983, Brain and Development.
[130] C. Torfs,et al. Maternal risk factors and major associated defects in infants with Down syndrome. , 1999, Epidemiology.
[131] R. ter Meulen. The ethical basis of the precautionary principle in health care decision making. , 2005, Toxicology and applied pharmacology.
[132] J. Simpson,et al. Are obese women at higher risk for producing malformed offspring? , 1994, American journal of obstetrics and gynecology.
[133] E. Orav,et al. Cardiovascular status of infants and children of women infected with HIV-1 (P2C2 HIV): a cohort study , 2002, The Lancet.
[134] G. Shaw,et al. Maternal use of cocaine during pregnancy and congenital cardiac anomalies. , 1991, The Journal of pediatrics.
[135] G. Shaw,et al. Maternal height and prepregnancy body mass index as risk factors for selected congenital anomalies. , 2000, Paediatric and perinatal epidemiology.
[136] E. Orav,et al. Cardiovascular abnormalities in infants prenatally exposed to cocaine. , 1991, The Journal of pediatrics.
[137] M. Schluchter,et al. Cardiac Complications in Children With Human Immunodeficiency Virus Infection , 1999, Pediatrics.
[138] A. Hofman,et al. Antiepileptic drug regimens and major congenital abnormalities in the offspring , 1999, Annals of neurology.
[139] J. Zhang,et al. Association of the common cold in the first trimester of pregnancy with birth defects. , 1993, Pediatrics.
[140] S. Shapiro,et al. Selected Birth Defects in Relation to Caffeine‐Containing Beverages , 1982, JAMA.
[141] W. Ray,et al. Prenatal Use of Metronidazole and Birth Defects: No Association , 1993, Obstetrics and gynecology.
[142] C. Azen,et al. Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy. , 2004, The Journal of pediatrics.
[143] E. Herrera,et al. Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E , 1996, Diabetologia.
[144] G. Shaw,et al. Maternal occupational chemical exposures and biotransformation genotypes as risk factors for selected congenital anomalies. , 2003, American journal of epidemiology.
[145] G. Saade,et al. A randomized double-blind study comparing the fetal effects of sulindac to terbutaline during the management of preterm labor. , 1999, American journal of obstetrics and gynecology.
[146] W. Cleland,et al. Congenital complete heart block and persistent ductus arteriosus associated with maternal systemic lupus erythematosus. , 1981, British heart journal.
[147] A. Krolewski,et al. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. , 1985, The New England journal of medicine.
[148] J. Lloyd,et al. TIMING OF STRICT DIET IN RELATION TO FETAL DAMAGE IN MATERNAL PHENYLKETONURIA An International Collaborative Study by the MRC/DHSS Phenylketonuria Register , 1987, The Lancet.
[149] A. Richens,et al. Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop , 2003, Epilepsy Research.
[150] U. Eriksson,et al. Pregnant Diabetic Rats Fed the Antioxidant Butylated Hydroxytoluene Show Decreased Occurrence of Malformations in Offspring , 1996, Diabetes.
[151] M. Norton. Teratogen update: fetal effects of indomethacin administration during pregnancy. , 1997, Teratology.
[152] B. Källén,et al. Nonsteroidal anti-inflammatory drugs in early pregnancy. , 2001, Reproductive toxicology.
[153] V. McKusick,et al. Parental age effects on the occurrence of new mutations for the Marfan syndrome , 1972, Annals of human genetics.
[154] J. Hanson. Teratogen update: fetal hydantoin effects. , 1986, Teratology.
[155] A. Fantel,et al. Fetal coronary thrombosis as a cause of single ventricular heart. , 1991, Teratology.
[156] S. Coughlin. Applications of the concept of attributable fraction in medical genetics. , 1992, American journal of medical genetics.
[157] C. Loffredo,et al. Attributable fraction for cardiac malformations. , 1998, American journal of epidemiology.
[158] G. Shaw,et al. Maternal pesticide exposure from multiple sources and selected congenital anomalies. , 1999 .
[159] K. Rothman,et al. Teratogenicity of high vitamin A intake. , 1996, The New England journal of medicine.
[160] M. Weinstein. Lithium Treatment of Women During Pregnancy and in the Post-Delivery Period , 1980 .
[161] E. Bermejo,et al. Risk for congenital anomalies associated with different sporadic and daily doses of alcohol consumption during pregnancy: a case-control study. , 2004, Birth defects research. Part A, Clinical and molecular teratology.
[162] C. Azen,et al. Role of nutrition in pregnancy with phenylketonuria and birth defects. , 2003, Pediatrics.
[163] J. Mulinare,et al. Risk factors for conotruncal cardiac defects in Atlanta. , 1989, Journal of the American College of Cardiology.
[164] Premature closure of the fetal ductus arteriosus after maternal use of non‐steroidal anti‐inflammatory drugs , 1998, The Medical journal of Australia.
[165] S. Schwartz,et al. Congenital malformations in newborns of women with established and gestational diabetes in Washington State, 1984-91. , 1996, Paediatric and perinatal epidemiology.
[166] J. Olsen,et al. Oral phenoxymethylpenicillin treatment during pregnancy. Results of a population-based Hungarian case-control study. , 2000, Archives of gynecology and obstetrics.
[167] L. Cousins. Etiology and prevention of congenital anomalies among infants of overt diabetic women. , 1991, Clinical obstetrics and gynecology.
[168] M. Longnecker,et al. The National Children's Study of environmental effects on child health and development. , 2003, Environmental health perspectives.
[169] K. Moise,et al. Prostaglandin synthetase inhibitors in pregnancy. , 1993, Obstetrical & gynecological survey.
[170] D. Bartley,et al. Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. , 1997, American journal of medical genetics.
[171] L. McCowan,et al. Antenatal Indomethacin‐Adverse Fetal Effects Confirmed , 1998, The Australian & New Zealand journal of obstetrics & gynaecology.
[172] J. Erickson,et al. Congenital Heart Defects, Maternal Febrile Illness, and Multivitamin Use: A Population-Based Study , 2001, Epidemiology.
[173] M. Bracken. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. , 1990, Obstetrics and gynecology.
[174] G. Shaw,et al. Maternal life event stress and congenital anomalies. , 2000, Epidemiology.
[175] P. Pradat. Effect of fathers' age and birth order on occurrence of congenital heart disease. , 1992, Journal of epidemiology and community health.
[176] Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester , 1992, The Lancet.
[177] B. Turner,et al. Prenatal Zidovudine Use and Congenital Anomalies in a Medicaid Population , 2000, Journal of acquired immune deficiency syndromes.
[178] J. Mulinare,et al. Maternal Fever, Multivitamin Use, and Selected Birth Defects: Evidence of Interaction? , 2002, Epidemiology.
[179] K. Rothman,et al. A Prospective Study of the Risk of Congenital Defects Associated with Maternal Obesity and Diabetes Mellitus , 2000, Epidemiology.
[180] R W Smithells,et al. Recognition of thalidomide defects. , 1992, Journal of medical genetics.
[181] M. Werler,et al. Maternal vitamin A supplementation in relation to selected birth defects. , 1990, Teratology.
[182] O. Heinonen,et al. Risk factors for atrial septal defect , 1992, European Journal of Epidemiology.
[183] R. Truex,et al. Association of maternal systemic lupus erythematosus with congenital complete heart block. , 1977, The New England journal of medicine.
[184] K. Moise,et al. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use. , 1993, American journal of obstetrics and gynecology.
[185] B. Thomson,et al. Viruses and apoptosis , 2001, International journal of experimental pathology.
[186] M. Edwards. Apoptosis, the heat shock response, hyperthermia, birth defects, disease and cancer. Where are the common links? , 1998, Cell stress & chaperones.
[187] M. Khoury,et al. Cocaine and single ventricle: a population study. , 1992, Teratology.
[188] K. Furie,et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.
[189] S. Ruddy,et al. Congenital Heart Block in Newborns of Mothers with Connective Tissue Disease , 1977, Circulation.
[190] S. Rasmussen,et al. Maternal lifestyle factors and risk for ventricular septal defects. , 2004, Birth defects research. Part A, Clinical and molecular teratology.
[191] A. Skrondal,et al. Water chlorination and birth defects. , 1999, Epidemiology.
[192] L D Edmonds,et al. The National Birth Defects Prevention Study , 2001, Public health reports.
[193] C. Loffredo,et al. Risk factors for heart disease associated with abnormal sidedness. , 2002, Teratology.
[194] J. Boughman,et al. Total anomalous pulmonary venous return: familial and environmental factors. The Baltimore-Washington Infant Study Group. , 1991, Teratology.
[195] C. Loffredo,et al. Population-based study of l-transposition of the great arteries: possible associations with environmental factors. , 2003, Birth defects research. Part A, Clinical and molecular teratology.
[196] M. Loeken,et al. Neural Tube Defects in Embryos of Diabetic Mice: Role of the Pax-3 Gene and Apoptosis , 1997, Diabetes.
[197] D. Savitz,et al. Influence of paternal age, smoking, and alcohol consumption on congenital anomalies. , 1991, Teratology.
[198] J. Boughman,et al. Ebstein's malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group. , 1994, Teratology.
[199] D A Savitz,et al. Relation between ambient air quality and selected birth defects, seven county study, Texas, 1997-2000. , 2005, American journal of epidemiology.
[200] H. Dolk,et al. Evaluation of the impact of Chernobyl on the prevalence of congenital anomalies in 16 regions of Europe. EUROCAT Working Group. , 1999, International journal of epidemiology.
[201] G. Shaw,et al. Maternal corticosteroid use and risk of selected congenital anomalies. , 1999, American journal of medical genetics.
[202] G. Shaw,et al. Socio-economic status and risk of conotruncal heart defects and orofacial clefts. , 2003, Paediatric and perinatal epidemiology.
[203] E. Reece,et al. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. , 1995, American journal of obstetrics and gynecology.
[204] M. Ostensen. Nonsteroidal anti-inflammatory drugs during pregnancy. , 1998, Scandinavian journal of rheumatology. Supplement.